Evidence map›Paper›PMID 22935790›Full record

ArticleNature reviews. Drug discovery2012

Sting of Alzheimer's failures offset by upcoming prevention trials.

Asher Mullard

Abstract readNews
PubMed Publisher
In one paragraph

Article in Nature reviews. Drug discovery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Subthreshold Amyloid Predicts Tau Deposition in Aging.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  9. Article
  10. Review
  11. Resveratrol for Alzheimer's disease.Annals of the New York Academy of Sciences · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.Movement disorders : official journal of the Movement Disorder Society · 2015
    Article
  18. Review
  19. Article
  20. S-Nitrosylation in Alzheimer's disease.Molecular neurobiology · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Asher Mullard

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedClinical Trials as TopicHumansPlaque, AmyloidTreatment FailureAntibodies, MonoclonalAntibodies, Monoclonal, Humanizedcrenezumab

Identifiers

PMID22935790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.